Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...

For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people ...

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

Chronic Kidney Disease (CKD) affects approximately 15% of U.S. adults and as many as 9 in 10 with CKD are unaware they have ...

Research led by Children's Hospital of Fudan University in China has found that a gene called pancreatic progenitor cell ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

CHMP recommends approval for XOANACYL, an oral therapy for use in the following therapeutic areas: Iron deficiency, chronic renal failure and hyperphosphatemiaFinal European Commission decision ...

Chicago: For a disease afflicting 35.5 million people in the US, chronic kidney disease flies under the radar. Only half the people who have it are formally diagnosed. The consequences of advanced ...

Anyone who has diabetes, high blood pressure, heart problems or has a family history of the disease is at increased risk for ...

Researchers from Peking University have launched the Kidney Imageomics Project to develop a "digital kidney" — a ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...